GT Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2015 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
GT Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2015 to 2023.
  • GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 2.23M shares, a 63.4% increase year-over-year.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.35M shares, a 26.9% increase from 2022.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.06M shares, a 96.2% decline from 2021.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.2M shares.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.35M +285K +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 1.06M -27.1M -96.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 28.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2018 50.2K -16.7M -99.7% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-29
2017 16.8M +16.7M +20486% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 81.5K -2.31M -96.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 2.39M Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.